Detalhe da pesquisa
1.
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.
Circulation
; 149(6): 450-462, 2024 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37952217
2.
Resistant Hypertension in Dialysis: Epidemiology, Diagnosis, and Management.
J Am Soc Nephrol
; 35(4): 505-514, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38227447
3.
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
N Engl J Med
; 385(27): 2507-2519, 2021 12 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34739197
4.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
N Engl J Med
; 385(24): 2252-2263, 2021 12 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34449181
5.
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
N Engl J Med
; 384(17): 1601-1612, 2021 04 29.
Artigo
Inglês
| MEDLINE | ID: mdl-33913638
6.
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
N Engl J Med
; 384(17): 1589-1600, 2021 04 29.
Artigo
Inglês
| MEDLINE | ID: mdl-33913637
7.
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
Curr Treat Options Oncol
; 25(1): 127-160, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38177560
8.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Ann Intern Med
; 176(12): 1606-1616, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38048573
9.
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
Circulation
; 145(6): 437-447, 2022 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34775784
10.
Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials.
Circulation
; 145(19): 1460-1470, 2022 05 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35394821
11.
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.
Kidney Int
; 103(1): 196-206, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36367466
12.
Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors.
Oncologist
; 28(10): 911-916, 2023 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37543031
13.
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
N Engl J Med
; 383(23): 2219-2229, 2020 Dec 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33264825
14.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Am J Kidney Dis
; 82(1): 84-96.e1, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36889425
15.
Hypertension in chronic kidney disease-treatment standard 2023.
Nephrol Dial Transplant
; 38(12): 2694-2703, 2023 Nov 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37355779
16.
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.
Nephrol Dial Transplant
; 38(1): 203-211, 2023 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36069890
17.
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE).
Nephrol Dial Transplant
; 38(4): 894-903, 2023 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35700142
18.
Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.
Nephrol Dial Transplant
; 38(10): 2358-2367, 2023 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37096396
19.
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.
Diabetes Obes Metab
; 25(6): 1646-1657, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36782093
20.
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use.
Diabetes Obes Metab
; 25(2): 407-416, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36193847